Evategrel could offer rapid and consistent platelet inhibition through oral and intravenous formulations, but early volunteer data cannot establish cardiovascular protection or safety.
Find out how Medtronic’s Scientia Vascular acquisition could reshape neurovascular access, stroke workflows and medtech competition.
Bayer needs a new cardiovascular growth engine. Asundexian’s FDA priority review now tests whether Factor XIa can move from promise to practice.
Distal stroke has long lacked device options. Rapid Medical’s TIGERTRIEVER 13 data now tests whether small-vessel thrombectomy can scale.
Life Recovery Systems begins pivotal ThermoSuit stroke trial to test rapid cooling therapy. Discover what this could mean for neuroprotection in ischemic stroke.
Life Recovery Systems (LRS), a medical device developer headquartered in Alexandria, Louisiana, has received an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration to advance its ThermoSuit System into a pivotal clinical trial enrolling ischemic stroke patients. The study, which will enroll up to 160 patients across as many as eight hospitals,